Sean Salmon - 13 Dec 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role: EVP & President Cardiovascular
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol: MDT
Transactions as of: 13 Dec 2022
Net transactions value: -$418,709
Form type: 4
Filing time: 16 Dec 2022, 06:28:19 UTC
Previous filing: 09 Dec 2022
Next filing: 02 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Options Exercise	$100,019	+1,808	+5%	$55.32	37,896	13 Dec 2022	Direct
transaction	MDT	Ordinary Shares	Options Exercise	$820,008	+14,823	+39%	$55.32	52,719	13 Dec 2022	Direct
transaction	MDT	Ordinary Shares	Sale	$1,338,736	-16,631	-32%	$80.50	36,088	13 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Stock Option (Right to Buy)	Options Exercise	$0	-1,808	-100%	$0.000000^*	0	13 Dec 2022	Ordinary Shares	1,808	$55.32	Direct
transaction	MDT	Stock Option (Right to Buy)	Options Exercise	$0	-14,823	-100%	$0.000000^*	0	13 Dec 2022	Ordinary Shares	14,823	$55.32	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.48 to $80.545 inclusive. The reporting person undertakes to provide Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.48 to $80.545 inclusive. The reporting person undertakes to provide Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.